Evidence map›Paper›PMID 22038448›Full record

ArticleTransgenic research2012

Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue.

Liwen Zhang, Yuchen Zhou, Amber Ying Zhu, Xiang-qing Li, Steven S Mundt, Ling Gao, JeanMarie Lisnock, Melba Hernandez, Magdalena Alonso-Galicia, Martin S Springer and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Liwen ZhangDepartment of Cardiovascular Diseases, Merck Research Laboratories, Rahway, NJ 07065, USA.
Yuchen Zhou
Amber Ying Zhu
Xiang-qing Li
Steven S Mundt
Ling Gao
JeanMarie Lisnock
Melba Hernandez
Magdalena Alonso-Galicia
Martin S Springer
Edward A O'Neill
Bruce L Daugherty
Oscar Puig

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome is a combination of medical disorders that increases the risk of developing cardiovascular disease and diabetes. Constitutive overexpression of 11β-HSD1 in adipose tissue in mice leads to metabolic syndrome. In the process of generating transgenic mice overexpressing 11β-HSD1 in an inducible manner, we found a metabolic syndrome phenotype in control, transgenic mice, expressing the reverse tetracycline-transactivator (rtTA) in adipose tissue. The control mice exhibited all four sequelae of metabolic syndrome (visceral obesity, insulin resistance, dyslipidemia, and hypertension), a pro-inflammatory state and marked hepatic steatosis. Gene expression profiling of the adipose tissue, muscle and liver of these mice revealed changes in expression of genes involved in lipid metabolism, insulin resistance, and inflammation. Transient transfection of rtTA, but not tTS, into 3T3-L1 cells resulted in lipid accumulation. We conclude that expression of rtTA in adipose tissue causes metabolic syndrome in mice.

Indexed as

Transcriptional Activation11-beta-Hydroxysteroid Dehydrogenase Type 13T3-L1 CellsAdipose TissueAnimalsBlood PressureChromosomes, MammalianDNA FragmentationFatty LiverGene Expression ProfilingInsulin ResistanceLipid MetabolismMaleMetabolic SyndromeMiceMice, Transgenic11-beta-Hydroxysteroid Dehydrogenase Type 1TetracyclineTrans-Activators

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.